RHUMBLINE ADVISERS - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 41 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2017. The put-call ratio across all filers is 8.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2021$68,000
-9.3%
30,467
+0.3%
0.00%
Q4 2020$75,000
+15.4%
30,367
+14.4%
0.00%
Q3 2020$65,000
-47.6%
26,534
-23.8%
0.00%
Q2 2020$124,000
+49.4%
34,839
-17.3%
0.00%
Q1 2019$83,000
+48.2%
42,145
-1.0%
0.00%
Q4 2018$56,000
-22.2%
42,560
+44.9%
0.00%
Q3 2018$72,000
-28.7%
29,380
-2.7%
0.00%
Q2 2018$101,000
-10.6%
30,180
+13.5%
0.00%
Q1 2018$113,000
+37.8%
26,600
+7.3%
0.00%
Q4 2017$82,000
-30.5%
24,780
-19.9%
0.00%
Q3 2017$118,000
-11.9%
30,952
+1.7%
0.00%
Q2 2017$134,00030,4320.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2017
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 277,177$915,0000.11%
WEBSTER BANK, N. A. 50,000$165,0000.02%
Brown Advisory Securities, LLC 28,000$92,0000.02%
SIMPLEX TRADING, LLC 50,804$167,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$83,0000.00%
GROUP ONE TRADING, L.P. 89,372$295,0000.00%
Squarepoint Ops LLC 10,194$34,0000.00%
Tower Research Capital LLC (TRC) 1,851$6,0000.00%
WOLVERINE TRADING, LLC 58,500$193,0000.00%
WOLVERINE TRADING, LLC 61,690$204,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders